Role of aspirin in primary prevention of cardiovascular disease

Role of aspirin in primary prevention of cardiovascular disease

The benefits of aspirin therapy for the secondary prevention of cardiovascular disease clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in this setting. However, no clear consensus exists about whether, and if so in whom, aspirin therapy is appropriate for the pr...

書誌詳細
主要な著者:	Patrono, C, Baigent, C
フォーマット:	Journal article
言語:	English
出版事項:	Springer Nature 2019

類似資料

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
著者:: Baigent, C, 等
出版事項: (2003)

Low-dose aspirin for the prevention of atherothrombosis.
著者:: Patrono, C, 等
出版事項: (2005)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
著者:: Patrono, C, 等
出版事項: (2005)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
著者:: Patrono, C, 等
出版事項: (2010)

Prevention. Aspirin in primary prevention--good news and bad news.
著者:: Hennekens, C, 等
出版事項: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
著者:: Hennekens, C, 等
出版事項: (2012)

Aspirin in the primary prevention of vascular disease Reply
著者:: Baigent, C, 等
出版事項: (2009)

Aspirin in the primary prevention of vascular disease Reply
著者:: Baigent, C, 等
出版事項: (2009)

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.
著者:: Patrono, C, 等
出版事項: (2009)

Aspirin overutilization for the primary prevention of cardiovascular disease
著者:: VanWormer JJ, 等
出版事項: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
著者:: Ying Xing, 等
出版事項: (2019-07-01)

Aspirin for disease prevention: public policy or personal choice?
著者:: Baigent, C
出版事項: (2016)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
著者:: Eleni Giannopoulou, 等
出版事項: (2024-12-01)

Polypills with or without aspirin for primary prevention of cardiovascular disease
著者:: Mant, J, 等
出版事項: (2021)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
著者:: Price, H, 等
出版事項: (2009)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
著者:: Hennekens, C, 等
出版事項: (1989)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
著者:: Hennekens, C, 等
出版事項: (2006)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
著者:: Baigent, C, 等
出版事項: (2009)

Aspirin, platelet inhibition and cancer prevention
著者:: Paola Patrignani, 等
出版事項: (2018-11-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
著者:: Yinong Chen, 等
出版事項: (2021-09-01)

Aspirin for prevention of cancer and cardiovascular disease.
著者:: Rose, P, 等
出版事項: (2011)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
著者:: Athena L. Huang, 等
出版事項: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
著者:: Athena L. Huang, MD, 等
出版事項: (2023-09-01)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
著者:: Xie W, 等
出版事項: (2019-09-01)

Analysis of the Dilemma Involving Statins and Aspirin as Primary Prevention Alternatives in Cardiovascular Disease
著者:: Henry Sutanto
出版事項: (2017-10-01)

Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis.
著者:: Inge Stegeman, 等
出版事項: (2015-01-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
著者:: L. A. Strizhakov
出版事項: (2012-04-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
出版事項: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
著者:: Randall S Stafford, 等
出版事項: (2005-12-01)

2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease
著者:: Xiao-Ying Li, 等
出版事項: (2020-05-01)

Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
著者:: Hadar Haim-Pinhas, 等
出版事項: (2022-10-01)

Aspirin use for cardiovascular disease prevention in the uninsured population
著者:: Nina Liu, 等
出版事項: (2020-06-01)

Coxibs, traditional NSAIDs and cardiovascular safety post-PRECISION: What we thought we knew then and what we think we know now
著者:: Patrono, C, 等
出版事項: (2017)

Effects of aspirin for primary prevention in persons with diabetes mellitus
著者:: Bowman, L, 等
出版事項: (2018)

Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
著者:: Alberto Aimo, 等
出版事項: (2020-01-01)

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
著者:: Georg Gelbenegger, 等
出版事項: (2019-11-01)

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
著者:: Tzeyu L. Michaud, 等
出版事項: (2015-12-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
著者:: Collins, R, 等
出版事項: (1996)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
著者:: Guillaume Marquis‐Gravel, 等
出版事項: (2024-02-01)

Aspirin for everyone older than 50? Against.
著者:: Baigent, C
出版事項: (2005)